Main Session: Collaborative Management of Patients with Advanced Estrogen Receptor-Positive Breast Cancer

At what point does a patient become a candidate for treatment with CDK inhibitors?

Lee S. Schwartzberg, MD, FACP
West Cancer Center

Related Material

What are the most common side effects of CDK inhibitors?

What do APs need to know about hematologic side effects and how to manage them?

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.